Search Results - "Matsumura, Tsuyoshi"

Efficacy of tranilast in preventing exacerbating cardiac function and death from heart failure in muscular dystrophy patients with advanced-stage heart failure: a single-arm, open-label, multicenter study.

Authors: Matsumura, Tsuyoshi Fukudome, Takayasu Motoyoshi, Yasufumi et al.

Source: Orphanet Journal of Rare Diseases. 1/9/2025, Vol. 20 Issue 1, p1-9. 9p.

Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.

Authors: Nakamura, Akinori Matsumura, Tsuyoshi Ogata, Katsuhisa et al.

Source: Annals of Clinical & Translational Neurology. Dec2023, Vol. 10 Issue 12, p2360-2372. 13p.

Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1.

Authors: Takada, Hiroto Matsumura, Tsuyoshi Shimamura, Haruna et al.

Source: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5252. 11p.

Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study.

Authors: Matsumura, Tsuyoshi Hashimoto, Hiroya Sekimizu, Masahiro et al.

Source: Orphanet Journal of Rare Diseases. 5/16/2022, Vol. 17 Issue 1, p1-10. 10p.

Infection control in the respiratory care of coronavirus disease‐19 patients with neuromuscular diseases.

Authors: Matsumura, Tsuyoshi Saito, Toshio Mori, Masahide et al.

Source: Neurology & Clinical Neuroscience. Mar2021, Vol. 9 Issue 2, p159-165. 7p.

Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study.

Authors: Fujino, Haruo Takahashi, Masanori P. Nakamura, Harumasa et al.

Source: Disability & Rehabilitation. Dec2024, Vol. 46 Issue 25, p6169-6178.

Hematopoietic Prostaglandin D Synthase Is Increased in Mast Cells and Pericytes in Autopsy Myocardial Specimens from Patients with Duchenne Muscular Dystrophy.

Authors: Hamamura, Kengo Yoshida, Yuya Oyama, Kosuke et al.

Source: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1846. 11p.

Author Index.

Source: International Journal of Urology. Dec2004, Vol. 11 Issue 12, p1158-1167. 10p.

Tracheostomy with invasive ventilation for ALS patients: Neurologists' roles in the US and Japan.

Authors: Rabkin, Judith Ogino, Mieko Goetz, Raymond et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Apr2013, Vol. 14 Issue 3, p116-123. 8p. 6 Charts.

Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy.

Authors: Komaki, Hirofumi Maegaki, Yoshihiro Matsumura, Tsuyoshi et al.

Source: Annals of Clinical & Translational Neurology. Feb2020, Vol. 7 Issue 2, p181-190. 10p.

Simultaneous measurement of the size and methylation of chromosome 4qA-D4Z4 repeats in facioscapulohumeral muscular dystrophy by long-read sequencing.

Authors: Hiramuki, Yosuke Kure, Yuriko Saito, Yoshihiko et al.

Source: Journal of Translational Medicine. 11/8/2022, Vol. 20 Issue 1, p1-12. 12p.

Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study.

Authors: Komaki, Hirofumi Takeshima, Yasuhiro Matsumura, Tsuyoshi et al.

Source: Annals of Clinical & Translational Neurology. Dec2020, Vol. 7 Issue 12, p2393-2408. 16p.

Rubicon prevents autophagic degradation of GATA4 to promote Sertoli cell function.

Authors: Yamamuro, Tadashi Nakamura, Shuhei Yamano, Yu et al.

Source: PLoS Genetics. 8/5/2021, Vol. 17 Issue 8, p1-20. 20p.

Autism spectrum disorders are prevalent among patients with dystrophinopathies.

Authors: Fujino, Haruo Saito, Toshio Matsumura, Tsuyoshi et al.

Source: Neurological Sciences. Jul2018, Vol. 39 Issue 7, p1279-1282. 4p. 1 Chart.

Subjects: Autism spectrum disorders, Disease prevalence, Dystrophin, Symptoms, Autism, Muscle protein metabolism, Duchenne muscular dystrophy, Genetic techniques, Muscle proteins, Genetic mutation, Proteins, Comorbidity, Disease complications

Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast.

Authors: Takahashi, Chisato Oishi, Mariko Iwata, Yuko et al.

Source: International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p2167. 11p.

Integration of bioassay and non-target metabolite analysis of tomato reveals that β-carotene and lycopene activate the adiponectin signaling pathway, including AMPK phosphorylation.

Authors: Mohri, Shinsuke Takahashi, Haruya Sakai, Maiko et al.

Source: PLoS ONE. 7/1/2022, Vol. 17 Issue 7, p1-21. 21p.

Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1.

Authors: Fujino, Haruo Saito, Toshio Takahashi, Masanori P. et al.

Source: BMC Neurology. 2/14/2022, Vol. 22 Issue 1, p1-7. 7p.

A family with both X‐linked dominant Charcot–Marie–Tooth disease and myotonic dystrophy type 1 mutations with phenotypic variations.

Authors: Mori, Chiaki Nakatani, Rie Nakamori, Masayuki et al.

Source: Neurology & Clinical Neuroscience. Mar2019, Vol. 7 Issue 2, p88-90. 3p.

Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.

Authors: Nishi, Masamitsu Kimura, Takashi Igeta, Masataka et al.

Source: PLoS ONE. 5/14/2020, Vol. 15 Issue 5, p1-13. 13p.

Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.

Authors: Sasaki, Yusuke Asahiyama, Masato Tanaka, Toshiya et al.

Source: Scientific Reports. 5/8/2020, Vol. 10 Issue 1, p1-10. 10p.